Date/TimeDate(s) - May 10, 2022 - May 11, 2022
London, EC3A 7DB
NAMSA invites you to join us on 10-11 May at the upcoming LSX World Congress in London, UK. This event provides a unique forum for founders and CEOs of innovative biotech, medtech and healthtech organizations to discuss industry trends and best practices, as well as share real-world experiences among industry peers.
NAMSA EDUCATION SESSION
MedTech’s Post COVID-19 Transformation Growth Strategy – How The ‘New Normal’ Became The ‘Here & Now’
Moderated by Tim Mitchell; Vice President, Strategic Programs
10 May 2022 | 9:30 AM BST
Description: To thrive in a post-Covid environment, medtech companies are taking a more nuanced approach to achieve long term growth within an already rapidly changed landscape. During this session, a panel of commercial leaders will discuss the current state of the exciting but challenging medtech market, including the factors placing pressure on profitability, developments and strategies in medtech’s M&A market, and the emergent partnership models and deal-making strategies being leveraged as innovation continues apace.
Attendees can expect to learn more about:
- The global medtech outlook post-COVID
- Europe vs. U.S.: How to remain competitive in varying markets and navigate the nuances associated with each
- Evolution of medtech and convergence of new advanced technologies
NAMSA’s medical device experts will be available on-site for consultations. We welcome the opportunity to discuss the various pathways to market and suggestions on how to most efficiently and cost-effectively achieve market success based on your unique project objectives. Please contact us to reserve your consultation time.